Quick Answer
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. reported Operating Income of $25.16 million for fiscal year 2025.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | $25.16M | -88.9% |
| 2024 | $227.35M | -63.2% |
| 2023 | $617.26M | -5.2% |
| 2022 | $650.98M | +10.4% |
| 2021 | $589.86M | +36.3% |
| 2020 | $432.73M | +23.2% |
| 2019 | $351.15M | +6.0% |
| 2018 | $331.38M | +15.0% |
| 2017 | $288.28M | +21.4% |
| 2016 | $237.55M | +15.1% |
| 2015 | $206.45M | +16.2% |
| 2014 | $177.67M | +17.4% |
| 2013 | $151.40M | -8.7% |
| 2012 | $165.76M | -4.9% |
| 2011 | $174.31M | +158.4% |
| 2010 | -$298.51M | -276.0% |
| 2009 | $169.61M | +137.5% |
| 2008 | -$451.84M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $133.80M | +14.0% | +33.6% |
| June 30, 2025 | $100.13M | -34.0% | +34.1% |
| March 31, 2025 | $74.67M | -40.7% | -36.4% |
| September 30, 2024 | $117.41M | -22.5% | -22.6% |
| June 30, 2024 | $151.65M | -8.1% | +20.4% |
| March 31, 2024 | $125.98M | -25.0% | -16.8% |
| September 30, 2023 | $151.50M | +0.3% | -8.1% |
| June 30, 2023 | $164.94M | -12.0% | -1.8% |
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. showed a decrease of -88.9% in Operating Income compared to the prior fiscal year.
- Over the 2008–2025 period, CHARLES RIVER LABORATORIES INTERNATIONAL, INC.’s operating income has grown by 105.6% (from -$451.84 million to $25.16 million).
- The most recent figure is from CHARLES RIVER LABORATORIES INTERNATIONAL, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 18, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: